110 related articles for article (PubMed ID: 8604591)
1. Clinical studies of iron chelators in malaria.
Mabeza GF; Biemba G; Gordeuk VR
Acta Haematol; 1996; 95(1):78-86. PubMed ID: 8604591
[TBL] [Abstract][Full Text] [Related]
2. Iron chelating agents for treating malaria.
Smith HJ; Meremikwu M
Cochrane Database Syst Rev; 2003; (2):CD001474. PubMed ID: 12804409
[TBL] [Abstract][Full Text] [Related]
3. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria.
Gordeuk V; Thuma P; Brittenham G; McLaren C; Parry D; Backenstose A; Biemba G; Msiska R; Holmes L; McKinley E
N Engl J Med; 1992 Nov; 327(21):1473-7. PubMed ID: 1406879
[TBL] [Abstract][Full Text] [Related]
4. Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria.
Thuma PE; Mabeza GF; Biemba G; Bhat GJ; McLaren CE; Moyo VM; Zulu S; Khumalo H; Mabeza P; M'Hango A; Parry D; Poltera AA; Brittenham GM; Gordeuk VR
Trans R Soc Trop Med Hyg; 1998; 92(2):214-8. PubMed ID: 9764337
[TBL] [Abstract][Full Text] [Related]
5. Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia.
Gordeuk VR; Thuma PE; Brittenham GM; Zulu S; Simwanza G; Mhangu A; Flesch G; Parry D
Blood; 1992 Jan; 79(2):308-12. PubMed ID: 1730079
[TBL] [Abstract][Full Text] [Related]
6. Control of malaria by drug-mediated iron deprivation.
Hershko C; Cabantchik ZI
Isr J Med Sci; 1994 Nov; 30(11):840-5. PubMed ID: 7982777
[No Abstract] [Full Text] [Related]
7. A standard regimen for treatment of plasmodium vivax malaria.
Patwari AK
Indian Pediatr; 1996 Sep; 33(9):792-4. PubMed ID: 9057417
[No Abstract] [Full Text] [Related]
8. The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria.
Hershko C; Gordeuk VR; Thuma PE; Theanacho EN; Spira DT; Hider RC; Peto TE; Brittenham GM
J Inorg Biochem; 1992 Aug 15-Sep; 47(3-4):267-77. PubMed ID: 1431886
[TBL] [Abstract][Full Text] [Related]
9. Antimalarial effect of iron chelators.
Gordeuk VR; Loyevsky M
Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
[No Abstract] [Full Text] [Related]
10. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
[TBL] [Abstract][Full Text] [Related]
11. UK malaria treatment guidelines.
Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
[TBL] [Abstract][Full Text] [Related]
12. Iron chelation therapy for malaria.
Gordeuk VR; Thuma PE; Brittenham GM
Adv Exp Med Biol; 1994; 356():371-83. PubMed ID: 7887243
[No Abstract] [Full Text] [Related]
13. Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria.
Mohanty D; Ghosh K; Pathare AV; Karnad D
Indian J Med Res; 2002 Jan; 115():17-21. PubMed ID: 12424933
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model.
Ferrer P; Tripathi AK; Clark MA; Hand CC; Rienhoff HY; Sullivan DJ
PLoS One; 2012; 7(5):e37171. PubMed ID: 22629364
[TBL] [Abstract][Full Text] [Related]
15. Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria from Thailand.
Bunnag D; Poltera AA; Viravan C; Looareesuwan S; Harinasuta KT; Schindléry C
Acta Trop; 1992 Sep; 52(1):59-67. PubMed ID: 1359761
[TBL] [Abstract][Full Text] [Related]
16. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
Boggild AK; Krudsood S; Patel SN; Serghides L; Tangpukdee N; Katz K; Wilairatana P; Liles WC; Looareesuwan S; Kain KC
Clin Infect Dis; 2009 Sep; 49(6):841-9. PubMed ID: 19673614
[TBL] [Abstract][Full Text] [Related]
17. Rectal versus intravenous quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomized, double-blind clinical trial.
Achan J; Byarugaba J; Barennes H; Tumwine JK
Clin Infect Dis; 2007 Dec; 45(11):1446-52. PubMed ID: 17990227
[TBL] [Abstract][Full Text] [Related]
18. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
Walsh DS; Eamsila C; Sasiprapha T; Sangkharomya S; Khaewsathien P; Supakalin P; Tang DB; Jarasrumgsichol P; Cherdchu C; Edstein MD; Rieckmann KH; Brewer TG
J Infect Dis; 2004 Oct; 190(8):1456-63. PubMed ID: 15378438
[TBL] [Abstract][Full Text] [Related]
20. [Plasmodium resistance to antimalarials].
Cailhol J; Consigny PH
Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
